Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer
Keywords: اسید زولدرونیک; Bisphosphonate; Chemotherapy; Antitumor activity; Neoplasm; Bone metastases; Lung cancer; Zoledronic acid